INHIBITOR THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0858 USD | +50.53% |
|
+25.26% | -6.74% |
| 03-29 | Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Introducing Inhibitor Therapeutics, Inc. Announces Scientific Advisory Board | CI |
Quotes 5-day view
Delayed Quote OTC Markets| 2024-04-17 | 2024-04-23 | 2024-04-24 | |
|---|---|---|---|
| Last | 0.0685 $ | 0.057 $ | 0.0858 $ |
| Volume | 400 | 100 | 250 |
| Change | +∞% | -16.79% | +50.53% |
| Opening | 0.07 | 0.06 | 0.09 |
| High | 0.07 | 0.06 | 0.09 |
| Low | 0.07 | 0.06 | 0.09 |
Performance
| 1 day | +50.53% | ||
| 1 week | +25.26% | ||
| Current month | +22.57% | ||
| 1 month | +22.57% | ||
| 3 months | -14.20% | ||
| 6 months | +66.60% | ||
| Current year | -6.74% | ||
| 1 year | +115.58% | ||
| 3 years | +37.28% | ||
| 5 years | +61.28% | ||
| 10 years | -59.14% |
Volumes
marketsDaily volume
250
Estimated daily volume
250
Avg. Volume 20 sessions
3 774
Daily volume ratio
0.07
Avg. Volume 20 sessions USD
323.81
Record volume 1
13 131 496
Record volume 2
5 568 257
Record volume 3
4 431 010
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
14 759 620
Net sales ()
0
Number of employees
6
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
41.51 %
Free-Float capitalization (USD)
6 126 179
Average Daily Capital Traded
0%
Highs and lows
1 week
0.06
0.09
1 month
0.050.10
Current year
0.030.12
1 year
0.010.30
3 years
0.010.35
5 years
0.010.35
10 years
0.010.65
Indicators
Moving average 20 days
0.07
Moving average 50 days
0.07
Moving average 100 days
0.08
Price spread / (MMA20)
-20.98%
Price spread / (MMA50)
-14.69%
Price spread / (MMA100)
-7.34%
STIM
RSI 9 days
57.14
RSI 14 days
54.23
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +50.53% | +25.26% | -6.74% | +115.58% | 14.76M | ||
| -0.06% | +0.81% | -2.31% | +22.94% | 103B | ||
| -0.84% | -1.52% | +0.56% | +13.52% | 95.28B | ||
| +0.90% | +3.56% | +1.69% | +0.60% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -21.15% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.49% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -37.19% | 16.74B | ||
| +3.38% | +18.58% | -14.85% | -37.58% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +32.39% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +5.31% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -33.33% | 8.24B | ||
| +7.91% | +17.17% | +299.30% | +280.10% | 8.19B | ||
| -0.75% | -3.05% | +7.90% | +77.79% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +51.30% | 7.71B | ||
| +5.81% | +6.81% | -54.46% | -71.20% | 7.17B | ||
| +0.72% | +5.24% | -1.21% | +28.46% | 6.99B | ||
| Average | +4.29% | +5.36% | +10.90% | +24.88% | ||
| Weighted average by Cap. | +0.42% | +1.87% | +2.08% | +12.83% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -6.74% | ||
| 2023 | -6.84% | ||
| 2022 | -34.06% | ||
| 2021 | +328.47% | ||
| 2020 | -37.31% | ||
| 2019 | -7.08% | ||
| 2018 | -76.10% | ||
| 2017 | -35.64% | ||
| 2016 | +200.00% | ||
| 2015 | +4.00% | ||
| 2014 | +52.44% | ||
| 2013 | +446.67% | ||
| 2012 | +15.38% | ||
| 2011 | -79.03% | ||
| 2010 | -83.90% | ||
| 2009 | +48.15% | ||
| 2008 | -89.80% | ||
| 2007 | +19.16% | ||
| 2006 | -55.42% | ||
| 2005 | -20.00% | ||
| 2004 | +86.92% | ||
| 2003 | +372.06% | ||
| 2002 | -75.00% | ||
| 2001 | -27.47% | ||
| 2000 | -59.04% | ||
| 1999 | +6.16% | ||
| 1998 | +2.99% | ||
| 1997 | -5.63% |
- Stock Market
- Equities
- INTI Stock
- Quotes Inhibitor Therapeutics, Inc.
